New drug tested for Tough-to-Treat blood cancers
NCT ID NCT04764474
Summary
This study tested a new oral drug called HMPL-306 for adults with advanced blood cancers that have returned, resisted treatment, or not responded to other therapies. The main goals were to find a safe dose and see how the body processes the drug. The trial was for patients whose cancers have specific genetic changes called IDH mutations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOCITRATE DEHYDROGENASE GENE MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Froedtert-Medical College of WI
Milwaukee, Wisconsin, 53226, United States
-
Hospital Clinico Universitario de Valencia
Valencia, Valencia, 46010, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario La Fe
Valencia, Valencia, 46026, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario de Salamanca
Salamanca, 58-182, Spain
-
Institut Catala d'Oncologia de l'Hospitalet de Llobregat - Hospital Duran i Reynals
Barcelona, 08908, Spain
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
START Madrid - Hospital Universitario Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center
Orange, California, 92868, United States
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
-
Winship Cancer Institute - Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.